WTO MINISTERIAL MEETING: LDC generic drugs push defeated
Low-developed countries tried hard but failed to secure a longer waiver for patent rights on the manufacture of generic medicines particularly those under Covid, besides the two years granted under the emergency waiver. Led by South Africa and India, poor countries faced stiff opposition from Europe.
